Palomino Laboratories (PALX) Payables (2022 - 2025)

Palomino Laboratories recorded quarterly Payables of $55687.0 in Q4 2025, down 8.64% quarter-over-quarter from $60952.0 in Q3 2025, and up 765.92% year-over-year from $6431.0 in Q4 2024.

Palomino Laboratories' Payables history runs 4 years deep, the most recent figure standing at $55687.0 for Q4 2025.

  • In Q4 2025, Payables rose 765.92% year-over-year to $55687.0; the TTM figure through Dec 2025 stood at $55687.0 (up 765.92% YoY), while the FY2025 annual figure was $55687.0, up 765.92% from the prior year.
  • Payables came in at $55687.0 for Q4 2025 at Palomino Laboratories, down from $60952.0 in the prior quarter.
  • In the past five years, Payables ranged from a high of $177004.0 in Q3 2024 to a low of $6431.0 in Q4 2024.
  • A 4-year average of $63031.8 and a median of $55687.0 in 2025 frame the typical range for Payables.
  • On a YoY basis, Payables climbed as much as 765.92% in 2025 and fell as far as 65.56% in 2025.
  • Palomino Laboratories' Payables stood at $12804.0 in 2022, then declined by 21.45% to $10058.0 in 2023, then sank by 36.06% to $6431.0 in 2024, then surged by 765.92% to $55687.0 in 2025.
  • According to Business Quant data, Payables over the past three periods registered $55687.0, $60952.0, and $60781.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 55,687.00
Sep 30, 2025 60,952.00
Jun 30, 2025 60,781.00
Mar 31, 2025 320,816.00
Dec 31, 2024 6,431.00
Sep 30, 2024 177,004.00
Jun 30, 2024 154,158.00
Mar 31, 2024 126,675.00
Dec 31, 2023 10,058.00
Sep 30, 2023 51,297.00
Dec 31, 2022 17,500.00